PIII NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

P3 Health Partners Inc · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 9.83 USD
2.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 62.5% above the Trend Line and sits at 54.1% of its 52-week range. The latest completed week returned 2.2%, after a -13.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 9d.

Setup score 48 out of 100
Latest Close 9.83 USD 31 Jul 2026
1W Return 2.2% latest completed week
4W Return -13.5% short-term follow-through
12W Return 177.1% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • The trend backdrop is active with a 10-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 41.35% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.2% Latest completed week; four-week move -13.5%. Indicator stack 50/49 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.35% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 56 relevant articles in the latest sentiment read. Event risk 9d Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 62.5% above the Trend Line and sits at 54.1% of its 52-week range. The latest completed week returned 2.2%, after a -13.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8712-week average 0.57

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.5% over four weeks, 177.1% over 12 weeks, and 33.7% over one year. The current trend has remained active for 10 consecutive weeks.

Performance by holding period

1W2.2%
4W-13.5%
12W177.1%
26W412.0%
52W33.7%
Active trend streak10 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.27Latest activity-pressure read.
Pressure change-73.4%Four-week change in activity pressure.
Leadership41.15Latest relative-leadership reading.
RS change-31.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 73% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength46/100Blend of value, momentum, and quality. Underlying universe rank 55; rank 1 is best.
Value48/100Relative valuation strength. Underlying universe rank 53; rank 1 is best.
Quality46/100Profitability and accounting quality. Underlying universe rank 55; rank 1 is best.
Momentum48/100Medium-term price momentum. Underlying universe rank 53; rank 1 is best.
Growth48/100Revenue and earnings growth. Underlying universe rank 53; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-105.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
50.6%
Gross profit retained from each unit of revenue.
Operating margin
-15.1%
Operating profit retained from revenue.
Free-cash-flow margin
-5.8%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-0.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity2 / 2

2 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 56 relevant articles.

16 positive · 34 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings9dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-41.8%Distance below the 52-week high.
13-week volatility58.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2610 weeks finished lower.
Best week+218.2%Week of 15 May.
Worst week-13.8%Week of 10 Jul.
Latest week+2.2%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks1
Modest losses3
Sharp losses7
Recent vol58.8%13-week weekly-return volatility.
Base vol32.2%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew18.7% / -8.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis85/100

Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.87; No reversal markers Next-Week ExpectancyNegative 41.35%

Next-week expectancy is negative with a 41.35% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 11; Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 56 relevant articles.

PIII|P3 Health Partners Inc|Price:10.005|Chg%:-0.495 Insiders2 / 2

2 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings9d

Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20269.83 USD2.2%6.05 USD24.56 USD0.2741.15126.1KOn
24 Jul 20269.62 USD-11.1%5.84 USD25.21 USD0.4939.1585.7KOn
17 Jul 202610.82 USD10.4%5.64 USD25.84 USD0.6954.3678.8KOn
10 Jul 20269.80 USD-13.8%5.41 USD26.53 USD0.8334.95181.4KOn
3 Jul 202611.37 USD0.5%5.26 USD27.30 USD1.0260.09162.1KOn
26 Jun 202611.31 USD5.2%5.06 USD28.10 USD1.1362.01111.6KOn
19 Jun 202610.75 USD-12.1%4.86 USD28.98 USD1.2248.31175.4KOn
12 Jun 202612.23 USD5.6%4.69 USD29.99 USD1.3174.13320.0KOn
5 Jun 202611.58 USD-4.9%4.51 USD31.16 USD1.4070.11789.6KOn
29 May 202612.18 USD-7.7%4.39 USD32.52 USD1.3172.20928.2KOn
22 May 202613.20 USD16.9%4.27 USD33.96 USD1.1492.878.9MOff
15 May 202611.29 USD218.2%4.13 USD34.99 USD0.8968.3366.7MOff
8 May 20263.55 USD21.1%4.04 USD36.15 USD0.59-47.21107.7KOff
1 May 20262.93 USD11.0%4.23 USD36.97 USD0.45-55.1945.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.